Unified Intervention to Impact HIV Care Continuum
统一干预措施影响艾滋病毒护理的连续性
基本信息
- 批准号:9328030
- 负责人:
- 金额:$ 70.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdherenceAdolescent and Young AdultAgeAlcohol consumptionAlcohol or Other Drugs useBehavioralCar PhoneCaringClinicClinical TrialsContinuity of Patient CareCounselingDataDiagnosisDoseDropsEconomicsElementsEnrollmentEpidemicFaceGeographic LocationsGoalsHIVHIV InfectionsHIV SeropositivityHIV-infected adolescentsHealthHuman immunodeficiency virus testImmune systemIncidenceIndividualInfectionInformal Social ControlInterventionLeftLinkLong-Term CareLongitudinal StudiesMedicalModelingMotivationOutcomeParticipantPersonsPhonationPilot ProjectsPopulationPrevalencePreventionProblem SolvingRNARandomizedRecordsRelapseResearchRiskRunningServicesSourceTechniquesTelephoneTestingTextTimeTreatment outcomeUnited States National Institutes of HealthViralVirus ReplicationWorkYouthalcohol and other drugantiretroviral therapybaseblack men who have sex with menclinical carecomparativecostcost effectivecost effectivenesseconomic evaluationeffective interventionevidence basehealth disparityimprovedmedical appointmentmedication compliancemotivational enhancement therapynumber theoryoutreachpreventrandomized trialskillssocialsocial mediasocial stigmasubstance using adolescentstheoriestherapy adherencetherapy designtransmission processtreatment adherenceyoung adult
项目摘要
This pragmatic adaptive clinical trial will test the effects of a Stigma-Motivational-Decision intervention
designed to increase HIV treatment engagement, retention, and medication adherence for substance using
adolescents and young adults (AYA) living with HIV who are not in clinical care. The intervention uses a
uniquely unified counseling approach at multiple points along the HIV continuum of care. In a first step, we will
use multiple modes of outreach including social media, passive media, clinic records, and chain referrals to
seek and identify HIV positive AYA (age 16 to 25) who are out of HIV care. In Step 2, HIV positive AYA who
are out of HIV care and substance using will be enrolled in a phone-delivered counseling intervention to
address substance use, HIV stigmas, medical care-related concerns, structural barriers, and other challenges
to engaging youth in HIV care. Counseling will be provided weekly until the time participants are engaged in
care, with a maximum of 12 sessions (up 3-months). We will therefore determine the number of theory-based
phone intervention sessions needed (minimally effective dose) for care engagement and the associated costs.
Once engaged in care, Step 3 will conduct a randomized trial to test the comparative effects and cost
effectiveness of interactive text messaging with opportunities for ongoing supportive problem solving versus
text message reminders to sustain long-term retention in care and medication adherence. HIV positive AYA
are likely to drop out of care because of known challenges such as substance use, social barriers such as
stigma, and concerns regarding treatment. Our 3-step study will use a single theory-based approach to
determine the number of phone-delivered Stigma-Motivational-Decision counseling intervention sessions
necessary to achieve engagement or re-engagement in HIV care, and will test the effects of a low-cost
approach to sustaining long-term retention in care and medication adherence. Participants will be out of
care at baseline and counseled with up to 12 weekly phone-delivered intervention sessions until they
confirm engagement in HIV care. The study will determine the minimally effective counseling dose needed
to engage substance using HIV positive AYA in care. Once participants attend HIV medical appointments,
they will be randomized to either: (a) 15-months of ongoing weekly mobile phone text message check-ins
with the opportunity for brief problem-focused phone support or (b) weekly text message reminders. The
study will test the effects of the counseling and text messaging interventions on maintaining HIV care
retention, medication adherence, and HIV viral suppression over 18-months. The primary endpoint in this
trial is HIV RNA suppression. We will perform economic evaluations to determine the cost-effectiveness of
the engagement-retention-adherence intervention. The proposed pragmatic adaptive trial will therefore
determine the minimally effective dose of counseling and the effects of a low-burden retention/adherence
intervention to maintain retention in care and avoid relapse to non-adherence for AYA living with HIV.
这项实用的适应性临床试验将测试污名动机决策干预的效果
旨在增加艾滋病毒治疗的参与,保留和药物使用的药物依从性
未接受临床护理的艾滋病毒感染者青少年和年轻人。干预使用一个
在艾滋病毒连续护理的多个沿着点采用独特的统一咨询方法。第一步,我们将
使用多种外展模式,包括社交媒体、被动媒体、诊所记录和连锁转诊,
寻找和识别艾滋病毒阳性的AYA(16至25岁),他们没有艾滋病毒护理。第二步,艾滋病毒阳性的AYA,
艾滋病毒护理和物质使用将被登记在一个电话提供的咨询干预,
解决药物使用、艾滋病毒污名、医疗保健相关问题、结构性障碍和其他挑战
让年轻人参与艾滋病毒护理。咨询将每周提供,直到时间参与者从事
护理,最多12次(最多3个月)。因此,我们将确定基于理论的
护理参与所需的电话干预会话(最低有效剂量)和相关成本。
一旦从事护理,步骤3将进行随机试验,以测试比较效果和成本
互动短信的有效性,有机会持续支持解决问题,
短信提醒,以维持长期保持护理和药物依从性。艾滋病毒阳性AYA
由于已知的挑战,如物质使用,社会障碍,
耻辱和对治疗的担忧。我们的三步研究将使用单一的基于理论的方法,
确定电话提供的污名-动机-决策咨询干预会议的次数
实现参与或重新参与艾滋病毒护理所必需的,并将测试低成本
维持长期护理和药物依从性的方法。参与者将在
在基线时进行护理,并通过每周最多12次的电话干预进行咨询,
确认参与艾滋病毒护理。这项研究将确定所需的最低有效咨询剂量
让艾滋病毒阳性的AYA参与护理。一旦参与者参加艾滋病毒医疗预约,
他们将被随机分配到:(a)15个月的每周移动的手机短信签到
有机会获得针对问题的简短电话支持或(B)每周短信提醒。的
一项研究将测试咨询和短信干预对维持艾滋病护理的影响
保持,药物依从性和HIV病毒抑制超过18个月。本研究的主要终点
HIV RNA抑制试验。我们将进行经济评估,以确定
即完成-保留-坚持干预。因此,拟议的务实适应性试验将
确定咨询的最低有效剂量和低负担保留/坚持的效果
采取干预措施,以保持对艾滋病毒感染者的护理,避免复发,不再坚持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa A Eaton其他文献
Lisa A Eaton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa A Eaton', 18)}}的其他基金
Stigma and Substance Use as Barriers to PrEP Linkage, Uptake, Adherence, and Persistence among BMSM
污名和物质使用是 BMSM 之间 PrEP 联系、吸收、坚持和持久性的障碍
- 批准号:
10402891 - 财政年份:2021
- 资助金额:
$ 70.36万 - 项目类别:
Stigma and Substance Use as Barriers to PrEP Linkage, Uptake, Adherence, and Persistence among BMSM
污名和物质使用是 BMSM 之间 PrEP 联系、吸收、坚持和持久性的障碍
- 批准号:
10599285 - 财政年份:2021
- 资助金额:
$ 70.36万 - 项目类别:
Stigma and Substance Use as Barriers to PrEP Linkage, Uptake, Adherence, and Persistence among BMSM
污名和物质使用是 BMSM 之间 PrEP 联系、吸收、坚持和持久性的障碍
- 批准号:
10161475 - 财政年份:2021
- 资助金额:
$ 70.36万 - 项目类别:
Unified Approach to Address PrEP Cascade for BMSM
解决 BMSM PrEP 级联问题的统一方法
- 批准号:
9751972 - 财政年份:2018
- 资助金额:
$ 70.36万 - 项目类别:
Novel Stigma/Structural Interventions for Increasing HIV/STI Testing Among BMSM
增加 BMSM 中 HIV/STI 检测的新耻辱/结构性干预措施
- 批准号:
9357683 - 财政年份:2016
- 资助金额:
$ 70.36万 - 项目类别:
Unified Intervention to Impact HIV Care Continuum
统一干预措施影响艾滋病毒护理的连续性
- 批准号:
9233354 - 财政年份:2016
- 资助金额:
$ 70.36万 - 项目类别:
Serosorting Intervention for HIV Negative MSM
HIV 阴性 MSM 的血清分选干预
- 批准号:
8299473 - 财政年份:2011
- 资助金额:
$ 70.36万 - 项目类别:
Serosorting Intervention for HIV Negative MSM
HIV 阴性 MSM 的血清分选干预
- 批准号:
8657324 - 财政年份:2011
- 资助金额:
$ 70.36万 - 项目类别:
Serosorting Intervention for HIV Negative MSM
HIV 阴性 MSM 的血清分选干预
- 批准号:
8462298 - 财政年份:2011
- 资助金额:
$ 70.36万 - 项目类别:
Serosorting Intervention for HIV Negative MSM
HIV 阴性 MSM 的血清分选干预
- 批准号:
8843960 - 财政年份:2011
- 资助金额:
$ 70.36万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 70.36万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 70.36万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 70.36万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 70.36万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 70.36万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 70.36万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 70.36万 - 项目类别: